I’m especially interested in SMCI’s margin recovery and CRWV’s revenue visibility. Both are high-beta names with execution and financing risks, so I wouldn’t chase the after-hours rally. NVDA remains my preferred core exposure, while COHR and LITE could benefit from continued optical demand.
For now, I’m cautiously bullish on an AI hardware recovery. I’ll watch CPI, Treasury yields and COHR’s earnings for confirmation. If CRWV and SMCI hold their gains, it could signal the correction was mainly valuation-driven. I’d rather accumulate selectively on weakness than chase the rebound. 🐯📈
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- zubee·08-12 17:22SMCI margin recovery is the whole game for me too. If next quarter holds, I’d add a bit moreLikeReport
